DBMR Logo.png
Cancer Diagnostics Market Global Industry Analysis by Size, Business Strategies, Share, Growth, Trends, Revenue, Competitive Landscape and Developments Forecast by 2028 Companies Profiles BioNTech Diagnostics, Abbott, Agilent Technologies, Thermo Fisher Scientific, Koninklijke Philips N.V. and Others
July 08, 2021 05:09 ET | Data Bridge Market Research
PUNE, India, July 08, 2021 (GLOBE NEWSWIRE) -- Cancer Diagnostics Market report comprises of several market dynamics and estimations of the growth rate and the market value based on market dynamics...
AMR Logo.png
Cancer Diagnostics Market Size to Reach $280.59 Billion by 2028: Allied Market Research
June 07, 2021 10:03 ET | Allied Market Research
Portland, OR, June 07, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Cancer Diagnostics Market was pegged at $168.60 billion in 2020, and is estimated to...
4D-Path_logo_rgb_full-color.jpg
World-Renowned Cancer Oncologist, Health Consultant and Entrepreneur Dr. Nelson Teich Added to 4D Path’s Distinguished Advisory Board
May 04, 2021 10:00 ET | 4D Path
NEWTON, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, is pleased to announce that Dr. Nelson Teich, MD,...
gmi logo.jpg
Oncology Market revenue to cross USD 469.5 Bn by 2026: Global Market Insights, Inc.
January 12, 2021 04:00 ET | Global Market Insights, Inc
Selbyville, Delaware, Jan. 12, 2021 (GLOBE NEWSWIRE) -- According to latest report “Oncology Market by Cancer Diagnostics & Treatment (Cancer Diagnostics, Cancer Treatment), Cancer Type (Lung...
4D-Path_logo_web_full-color.jpg
Dr. Jennifer Levin Carter Joins Advisory Board of Novel Precision Oncology Platform Creator 4D Path
December 15, 2020 10:00 ET | 4D Path
NEWTON, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, is pleased to announce that Jennifer Levin Carter,...
4D-Path_logo_web_full-color.jpg
FDA Grants Breakthrough Designation to 4D Path for Novel Cancer Diagnostic Solution
November 18, 2020 10:00 ET | 4D Path
NEWTON, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, today announced that the U.S. Food & Drug...
Teledyne Princeton Instruments introduces Raman spectrometer for limitation-shattering, high-sensitivity performance in NIR
June 09, 2020 08:00 ET | Teledyne Princeton Instruments
TRENTON, N.J, June 09, 2020 (GLOBE NEWSWIRE) -- Teledyne Princeton Instruments, a Teledyne Technologies [NYSE:TDY] company,  and world-renowned manufacturer of scientific imaging and spectroscopy...
logo.png
Cancer Diagnostics Market to grow at 7.99% CAGR during (2019-2025) – Global Insights on Size, Share, Technology, Application, Key Trends, Growth Drivers, and Business Opportunities: Adroit Market Research
November 14, 2019 06:27 ET | Adroit Market Research
Dallas, Texas, Nov. 14, 2019 (GLOBE NEWSWIRE) -- The “Global Cancer Diagnostics Market Size 2018 by Technology (Imaging, Molecular Diagnostics, Biopsy and Others), by Application (Breast Cancer,...
PRPO logo.png
First Substantial Customer: Tennessee Oncology Internalizes Precipio’s HemeScreen™
September 30, 2019 11:10 ET | Precipio, Inc.
NEW HAVEN, Conn., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that Tennessee Oncology has selected Precipio’s HemeScreen RUO assay as...
PRPO logo.png
Clinical Validations for IV-Cell™ and HemeScreen™ Completed
September 26, 2019 10:53 ET | Precipio, Inc.
 Orders expected from several major labs both domestically and internationally NEW HAVEN, Conn., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO),...